Intercept Pharmaceuticals | Zysk Brutto Na Sprzedaży



Gross Profit On Sales Zmiana Data
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amarin USD 25.13M 1.78M 2025-03
Amgen USD 5.54B 430M 2025-03
Arrowhead Research -173085000 2.55M 2024-12
AstraZeneca USD 11.35B 819M 2025-03
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Incyte USD 985.09M 111.22M 2025-03
Ionis Pharmaceuticals USD 130.15M 92.6M 2025-03
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Novartis USD 10.23B 294M 2024-12
PTC Therapeutics USD 196.89M 10.95M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Intercept Pharmaceuticals Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.